Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • syngene

    Tag: syngene

    You Searched For "syngene"
    Syngene International Limited announces Q3 FY20 results

    Syngene International Limited announces Q3 FY20 results

    Medical Dialogues Bureau25 Jan 2020 11:00 AM IST
    Reports 11% revenue growth in Q3 to Rs. 539 Cr
    Syngene, Narayana Health, AIF launch CHAMPS- unique initiative to prevent, manage early onset of NCDs

    Syngene, Narayana Health, AIF launch CHAMPS- unique initiative to prevent, manage early onset of NCDs

    Medical Dialogues Bureau15 Aug 2019 9:30 AM IST
    The combined synergies of Narayana Health as a knowledge partner, Syngene and Biocon Foundation as funding partners and Agastya International as the...
    Biocon appoints Mayank Verma as Company Secretary, Compliance Officer

    Biocon appoints Mayank Verma as Company Secretary, Compliance Officer

    Farhat Nasim27 July 2019 9:00 AM IST
    Prior to joining the Biocon Group, Mayank Verma has worked with ING Vysya Bank Limited from 2007 to 2012.New Delhi: Biotechnology major, Biocon has...
    Biocon commercial rights on biosimilar adalimumab extends to global markets

    Biocon commercial rights on biosimilar adalimumab extends to global markets

    Farhat Nasim8 May 2019 9:45 AM IST
    Biocon, under the terms of its global partnership with Mylan for monoclonal antibodies, retains its economic interest in this expanded in-licensing...
    Syngene collaborates with BIRAC to set up Centre for Advanced Protein Studies

    Syngene collaborates with BIRAC to set up Centre for Advanced Protein Studies

    Garima7 April 2019 9:30 AM IST
    Bengaluru: Syngene International Ltd., a contract research organization, announced the opening of its Centre for Advanced Protein Studies (CAPS) by...
    Biocon sells 1.88 percent stake in Syngene for Rs 230 crore

    Biocon sells 1.88 percent stake in Syngene for Rs 230 crore

    Ruby Khatun Khatun19 May 2018 11:00 AM IST
    New Delhi: Biocon Ltd has sold close to 2% stake in its research arm Syngene International for an estimated Rs230 crore."Biocon, the promoter of...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok